Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance

Emergent BioSolutions (EBS) Misses Q2 EPS by 15c

August 3, 2017 4:59 PM EDT

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.11, $0.15 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $100.8 million versus the consensus estimate of $111.57 million.

... More